Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (6): 939-941    DOI: 10.12891/ceog4051.2018
Case Report Previous articles | Next articles
Cell-free DNA testing: is it reliable? A case report
S. G. Erzincan1, *(), N. C. Sayin1, C. Inan1, M. A. Yuce2, F. G. Varol1, S. Basaran3
1 Trakya University, Faculty of Medicine, Department of Obstetrics & Gynecology, Edirne, Turkey
2 Ekol Hospital, Department of Obstetrics & Gynecology, Edirne, Turkey
3 Istanbul University, Faculty of Medicine, Department of Medical Genetics , Istanbul, Turkey
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
In this article, the authors reported the findings of a false negative case of cell-free DNA (cfDNA) testing for trisomy 21. The cfDNA test was performed due to the increased nuchal translucency during the first trimester scan. After receiving the “normal” result of the test, the patient was followed up. However, intrauterine growth retardation and ventriculomegaly were detected in the second trimester of pregnancy and fetal karyotyping revealed trisomy 21.
Key words:  False negative cell-free DNA testing      Fetal aneuploidy      Prenatal diagnosis      Trisomy 21     
Published:  10 December 2018     
*Corresponding Author(s):  S. GURSOY ERZINCAN     E-mail:  elengursoy@hotmail.com

Cite this article: 

S. G. Erzincan, N. C. Sayin, C. Inan, M. A. Yuce, F. G. Varol, S. Basaran. Cell-free DNA testing: is it reliable? A case report. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 939-941.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4051.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I6/939

[1] B.F. Zhou, C.X. Duan, D.L. Tang. Methylmalonic acidemia in prenatal diagnosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 617-619.
[2] D. Lu, D. Cao, Q. Zhao, X. Chen. Prenatal diagnosis and genetic counseling of mosaicism for chromosome t (7; 14) with a favorable outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 427-428.
[3] W.B. Wang, Q. Wu, Y. Zhou, X. Zhong, Y. Ge, J. Zhang. A 10-year retrospective study on prenatal cytogenetic analyses[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 248-252.
[4] Q.C. Wu, W.B. Wang, L. Sun, Y.S. Xu, X.J. Xie, X.M. Ma, Z.Y. Su. Mutation analysis of the fibroblast growth factor receptor 3 gene in fetuses with thanatophoric dysplasia, type I[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 7-11.
[5] G. Szabó, J. Rigó Jr.. Prenatal ultrasound diagnosis of abdominal pregnancy of ovarian origin[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 977-979.
[6] W. Homola, M. Zimmer. Safety of amniocentesis in normal pregnancies and pregnancies considered high-risk due to fetal genetic anomalies – an observational study[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 403-407.
[7] D.Y. Ma, G. Liu, C.Y. Luo, A. Liu, J.J. Zhang, P. Hu, J. Cheng, Y.G. Wang, T. Jiang, J.F. Xu. A novel mutation in the mutations in the methyl-CpG-binding protein 2 (MECP2) gene in a Chinese patient with typical Rett syndrome and subsequent prenatal diagnosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 924-929.
[8] Bo Wang, Dan Lu, Zuliang Shi, Jian Ke, Qi Zhao, Hongjun Li. Prenatal diagnosis of a complex chromosomal rearrangement involving five chromosomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 797-799.
[9] Sun Young Jung, Yong Teak Oh, Suk Young Kim. Predict pregnancy outcomes of prenatal megaureter by prenatal ultrasonography[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 544-548.
[10] G. Capobianco, G. Virdis, C. Cherchi, A. Gulotta, P.L. Cherchi, S. Dessole. Diagnosis and management of fetal omphalocele: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 129-131.
[11] J. Han, X. Liu, Y. Zhao, Y. Zhang, L. Sun, X. Gu, X. Yang, Y. Li, Y. He. Prenatal diagnosis of absent pulmonary valve syndrome: results of a single-center experience in Beijing[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 834-838.
[12] L.J. Kong, L. Fan, G.H. Li, W.Y. Zhang. Prevalence of congenital malformations during pregnancy in China: screening by ultrasound examination[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 772-776.
[13] L. Zhen, A.H. Wu, C. Liao, D.Z. Li. Prediction of homozygous α-thalassemia-1 by nuchal translucency measurement at first trimester: is it possible?[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 545-547.
[14] K.H. Gou, X.C. Gao, L. Wang, A.Q. Yan, L. Xue, S. Han, L. Yang. Risk factors for perinatal birth defects in Zhangye: a long-term hospital-based study[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 581-583.
[15] H. Aksoy, S. Özyurt, Ü. Aksoy, Ö. Özdamar, E. Mutlu, Ş. Tutuş, M.A. Babayiğit, G. Açmaz. Interobserver reliability of sonographic fetal biometry in second trimester maternal serum screening[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 379-383.
No Suggested Reading articles found!